BST-2/tetherin is overexpressed in mammary gland and tumor tissues in MMTV-induced mammary cancer

Virology

Volumn 444, Issue 1-2, 2013, Pages 124-139

  Jones, Philip H ^a   Mahauad Fernandez, Wadie D ^a,b   Madison, Marisa N ^a   Okeoma, Chioma M ^a,b  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

AKT; BST 2; Cancer; CCL3; Epithelial cells; Human breast cancer; Mammary gland; MIP1 ; Mouse mammary tumor virus; PI3K; Tetherin; Transformation; Tumor

Indexed keywords

ALPHA INTERFERON; BONE MARROW STROMAL CELL ANTIGEN 2; CELL ANTIGEN; GAMMA INTERFERON; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE DISTRIBUTION; VIRUS CARCINOGENESIS; VIRUS INFECTION; VIRUS LOAD;

AKT; BONE MARROW STROMAL CELL ANTIGEN 2; BST-2; CANCER; CCL3; EPITHELIAL CELLS; FACS; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN BREAST CANCER; MACROPHAGE INFLAMMATORY PROTEIN 1-ALPHA; MAMMARY GLAND; MIP1Α; MIP1-Α/CCL3; MOUSE MAMMARY TUMOR VIRUS; NMUMG; NORMAL MURINE MAMMARY GLAND; PHOSPHOINOSITIDE 3 KINASE; PI3K; TETHERIN; TRANSFORMATION; TUMOR;

ANIMALS; ANTIGENS, CD; FEMALE; HOST-PATHOGEN INTERACTIONS; HUMANS; MALE; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PREGNANCY; RETROVIRIDAE INFECTIONS; TUMOR VIRUS INFECTIONS;

MOUSE MAMMARY TUMOR VIRUS; MUS;

EID: 84882883319     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.05.042     Document Type: Article

References (92)

1. Allred D.C., Medina D. The relevance of mouse models to understanding the development and progression of human breast cancer. J. Mammary Gland Biol. Neoplasia 2008, 13:279-288.
2. Barrett B.S., Smith D.S., Li S.X., Guo K., Hasenkrug K.J., Santiago M.L. A single nucleotide polymorphism in tetherin promotes retrovirus restriction in vivo. PLoS Pathog. 2012, 8:e1002596.
3. Burger J.A., Quiroga M.P., Hartmann E., Burkle A., Wierda W.G., Keating M.J., Rosenwald A. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood 2009, 113:3050-3058.
4. Cai D., Cao J., Li Z., Zheng X., Yao Y., Li W., Yuan Z. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis. BMC Cancer 2009, 9:102.
5. Callahan R., Smith G.H. MMTV-induced mammary tumorigenesis: gene discovery, progression to malignancy and cellular pathways. Oncogene 2000, 19:992-1001.
6. Callahan R., Smith G.H. Common integration sites for MMTV in viral induced mouse mammary tumors. J. Mammary Gland Biol. Neoplasia 2008, 13:309-321.
7. Cao W., Bover L., Cho M., Wen X., Hanabuchi S., Bao M., Rosen D.B., Wang Y.H., Shaw J.L., Du Q., Li C., Arai N., Yao Z., Lanier L.L., Liu Y.J. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J. Exp. Med. 2009, 206:1603-1614.
8. Chen R.F., Good R.A., Engelman R.W., Hamada N., Tanaka A., Nonoyama M., Day N.K. Suppression of mouse mammary tumor proviral DNA and protooncogene expression: association with nutritional regulation of mammary tumor development. Proc. Nat. Acad. Sci. U.S.A. 1990, 87:2385-2389.
9. Cheng, J.Q., Ruggeri, B., Klein, W.M., Sonoda, G., Altomare, D.A., Watson, D.K., Testa, J.R., 1996. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. Proc. Nat. Acad. Sci. U S A 93, 3636-3641.
10. Chu H., Wang J.J., Qi M., Yoon J.J., Chen X., Wen X., Hammonds J., Ding L., Spearman P. Tetherin/BST-2 is essential for the formation of the intracellular virus-containing compartment in HIV-infected macrophages. Cell Host Microbe. 2012, 12:360-372.
11. Courreges M.C., Burzyn D., Nepomnaschy I., Piazzon I., Ross S.R. Critical role of dendritic cells in mouse mammary tumor virus in vivo infection. J. Virol. 2007, 81:3769-3777.
12. Dafa-Berger A., Kuzmina A., Fassler M., Yitzhak-Asraf H., Shemer-Avni Y., Taube R. Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin. Virology 2012, 428:98-111.
13. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes Dev. 1999, 13:2905-2927.
14. Denley A., Gymnopoulos M., Hart J.R., Jiang H., Zhao L., Vogt P.K. Biochemical and biological characterization of tumor-associated mutations of p110alpha. Methods Enzymol. 2008, 438:291-305.
15. Dickson C., Smith R., Brookes S., Peters G. Tumorigenesis by mouse mammary tumor virus: proviral activation of a cellular gene in the common integration region int-2. Cell 1984, 37:529-536.
16. Durgam V.R., Tekmal R.R. The nature and expression of int-5, a novel MMTV integration locus gene in carcinogen-induced mammary tumors. Cancer Lett. 1994, 87:179-186.
17. Faedo M., Ford C.E., Mehta R., Blazek K., Rawlinson W.D. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer. Clin. Cancer Res. 2004, 10:4417-4419.
18. Fernandez-Cobo M., Melana S.M., Holland J.F., Pogo B.G. Transcription profile of a human breast cancer cell line expressing MMTV-like sequences. Infect. Agents Cancer 2006, 1:7.
19. Fisher B., Bauer M., Wickerham D.L., Redmond C.K., Fisher E.R., Cruz A.B., Foster R., Gardner B., Lerner H., Margolese R., et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 1983, 52:1551-1557.
20. Ford C.E., Faedo M., Crouch R., Lawson J.S., Rawlinson W.D. Progression from normal breast pathology to breast cancer is associated with increasing prevalence of mouse mammary tumor virus-like sequences in men and women. Cancer Res. 2004, 64:4755-4759.
21. Fougerat A., Gayral S., Malet N., Briand-Mesange F., Breton-Douillon M., Laffargue M. Phosphoinositide 3-kinases and their role in inflammation: potential clinical targets in atherosclerosis?. Clinical Sci. 2009, 116:791-804.
22. Fransson S., Abel F., Kogner P., Martinsson T., Ejeskar K. Stage-dependent expression of PI3K/Aktpathway genes in neuroblastoma. Int. J. Oncol. 2013, 42:609-616.
23. Garcia M., Wellinger R., Vessaz A., Diggelmann H. A new site of integration for mouse mammary tumor virus proviral DNA common to BALB/cf(C3H) mammary and kidney adenocarcinomas. EMBO J. 1986, 5:127-134.
24. Goffinet C., Homann S., Ambiel I., Tibroni N., Rupp D., Keppler O.T., Fackler O.T. Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu. J. Virol. 2010, 84:4089-4094.
25. Goto T., Kennel S.J., Abe M., Takishita M., Kosaka M., Solomon A., Saito S. A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood 1994, 84:1922-1930.
26. Gray D.A., McGrath C.M., Jones R.F., Morris V.L. A common mouse mammary tumor virus integration site in chemically induced precancerous mammary hyperplasias. Virology 1986, 148:360-368.
27. Gu G., Zhao D., Yin Z., Liu P. BST-2 binding with cellular MT1-MMP blocks cell growth and migration via decreasing MMP2 activity. J. Cell. Biochem. 2012, 113:1013-1021.
28. Guerrero J., Tobar N., Caceres M., Espinoza L., Escobar P., Dotor J., Smith P.C., Martinez J. Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-beta1 and TNF-alpha. Breast Cancer Res. Treat. 2010, 119:497-508.
29. Guzzo C., Jung M., Graveline A., Banfield B.W., Gee K. IL-27 increases BST-2 expression in human monocytes and T cells independently of type I IFN. Sci. Rep. 2012, 2:974.
30. Hammonds J., Wang J.J., Spearman P. Restriction of retroviral replication by tetherin/BST-2. Mol. Biol. Int. 2012, 2012:424768.
31. Homann S., Smith D., Little S., Richman D., Guatelli J. Upregulation of BST-2/tetherin by HIV infection in vivo. J. Virol. 2011, 85:10659-10668.
32. Hundemer M., Schmidt S., Condomines M., Lupu A., Hose D., Moos M., Cremer F., Kleist C., Terness P., Belle S., Ho A.D., Goldschmidt H., Klein B., Christensen O. Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma. Exp. Hematol. 2006, 34:486-496.
33. Johal H., Scott G.M., Jones R., Camaris C., Riordan S., Rawlinson W.D. Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis. J. Hepatol. 2009, 50:548-554.
34. Jones P.H., Maric M., Madison M.N., Maury W., Roller R.J., Okeoma C.M. BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1). Virology 2013, 438:37-49.
35. Jones P.H., Mehta H.V., Maric M., Roller R.J., Okeoma C.M. Bone marrow stromal cell antigen 2 (BST-2) restricts mouse mammary tumor virus (MMTV) replication in vivo. Retrovirology 2012, 9:10.
36. Jones P.H., Mehta H.V., Okeoma C.M. A novel role for APOBEC3: susceptibility to sexual transmission of murine acquired immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice. Retrovirology 2012, 9:50.
37. Ju X., Katiyar S., Wang C., Liu M., Jiao X., Li S., Zhou J., Turner J., Lisanti M.P., Russell R.G., Mueller S.C., Ojeifo J., Chen W.S., Hay N., Pestell R.G. Akt1 governs breast cancer progression in vivo. Proc. Nat. Ac. Sci. U S A 2007, 104:7438-7443.
38. Kelsey J.L. Breast cancer epidemiology: summary and future directions. Epidemiol. Rev. 1993, 15:256-263.
39. Kim H.H., van den Heuvel A.P., Schmidt J.W., Ross S.R. Novel common integration sites targeted by mouse mammary tumor virus insertion in mammary tumors have oncogenic activity. PloS One 2011, 6:e27425.
40. Kong W.S., Irie T., Yoshida A., Kawabata R., Kadoi T., Sakaguchi T. Inhibition of virus-like particle release of Sendai virus and Nipah virus, but not that of mumps virus, by tetherin/CD317/BST-2. Hiroshima. J. Med. Sci. 2012, 61:59-67.
41. Krugmann S., Hawkins P.T., Pryer N., Braselmann S. Characterizing the interactions between the two subunits of the p101/p110gamma phosphoinositide 3-kinase and their role in the activation of this enzyme by G beta gamma subunits. J. Biol. Chem. 1999, 274:17152-17158.
42. Kuriki K., Kamiakito T., Yoshida H., Saito K., Fukayama M., Tanaka A. Integration of proviral sequences, but not at the common integration sites of the FGF8 locus, in an androgen-dependent mouse mammary Shionogi carcinoma. Cell. Mol. Biol. (Noisy-le-grand Fr.) 2000, 46:1147-1156.
43. Langerod A., Zhao H., Borgan O., Nesland J.M., Bukholm I.R., Ikdahl T., Karesen R., Borresen-Dale A.L., Jeffrey S.S. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Breast Cancer Res.: BCR 2007, 9:R30.
44. Laplana M., Caruz A., Pineda J.A., Puig T., Fibla J. Association of BST-2 gene variants with HIV disease progression underscores the role of BST-2 in HIV type 1 infection. J. Infect. Dis. 2013, 207:411-419.
45. Lentzsch S., Gries M., Janz M., Bargou R., Dorken B., Mapara M.Y. Macrophage inflammatory protein 1-alpha (MIP-1 alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood 2003, 101:3568-3573.
46. Li Y., Galileo D.S. Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion. Cancer Cell Int. 2010, 10:34.
47. Liberatore R.A., Bieniasz P.D. Tetherin is a key effector of the antiretroviral activity of type I interferon in vitro and in vivo. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:18097-18101.
48. Liu Y., Wang C., Mueller S., Paul A.V., Wimmer E., Jiang P. Direct interaction between two viral proteins, the nonstructural protein 2CATPase and the capsid protein VP3, is required for enterovirus morphogenesis. PLoS Pathog. 2010, 6.
49. Mangeat B., Cavagliotti L., Lehmann M., Gers-Huber G., Kaur I., Thomas Y., Kaiser L., Piguet V. Influenza virus partially counteracts restriction imposed by tetherin/BST-2. J. Biol. Chem. 2012, 287:22015-22029.
50. Marchetti A., Buttitta F., Miyazaki S., Gallahan D., Smith G.H., Callahan R. Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J. Virol. 1995, 69:1932-1938.
51. Marcotte R., Muller W.J. Signal transduction in transgenic mouse models of human breast cancer-implications for human breast cancer. J. Mammary Gland Biol. Neoplasia 2008, 13:323-335.
52. Maroulakou I.G., Oemler W., Naber S.P., Tsichlis P.N. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Res. 2007, 67:167-177.
53. Mehta H.V., Jones P.H., Weiss J.P., Okeoma C.M. IFN-alpha and lipopolysaccharide upregulate APOBEC3 mRNA through different signaling pathways. J. Immunol. (Baltimore, Md.: 1950) 2012, 189:4088-4103.
54. Nakatani K., Sakaue H., Thompson D.A., Weigel R.J., Roth R.A. Identification of a human Akt3 (protein kinase B gamma) which contains the regulatory serine phosphorylation site. Biochem Biophys. Res. Commun. 1999, 257:906-910.
55. Neil S.J., Zang T., Bieniasz P.D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430.
56. Nusse R. Insertional mutagenesis in mouse mammary tumorigenesis. Curr. Top. Microbiol. Immunol. 1991, 171:43-65.
57. Okazaki T., Ebihara S., Asada M., Kanda A., Sasaki H., Yamaya M. Granulocyte colony-stimulating factor promotes tumor angiogenesis via increasing circulating endothelial progenitor cells and Gr1+CD11b+ cells in cancer animal models. Int. Immunol. 2006, 18:1-9.
58. Okeoma C.M., Huegel A.L., Lingappa J., Feldman M.D., Ross S.R. APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virions. Cell Host Microbe. 2010, 8:534-543.
59. Okeoma C.M., Lovsin N., Peterlin B.M., Ross S.R. APOBEC3 inhibits mouse mammary tumour virus replication in vivo. Nature 2007, 445:927-930.
60. Okeoma C.M., Low A., Bailis W., Fan H.Y., Peterlin B.M., Ross S.R. Induction of APOBEC3 in vivo causes increased restriction of retrovirus infection. J. Virol. 2009, 83:3486-3495.
61. Okeoma C.M., Petersen J., Ross S.R. Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection. J. Virol. 2009, 83:3029-3038.
62. Okeoma C.M., Shen M., Ross S.R. A novel block to mouse mammary tumor virus infection of lymphocytes in B10.BR mice. J. Virol. 2008, 82:1314-1322.
63. Perez-Caballero D., Zang T., Ebrahimi A., McNatt M.W., Gregory D.A., Johnson M.C., Bieniasz P.D. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 2009, 139:499-511.
64. Pillai S.K., Abdel-Mohsen M., Guatelli J., Skasko M., Monto A., Fujimoto K., Yukl S., Greene W.C., Kovari H., Rauch A., Fellay J., Battegay M., Hirschel B., Witteck A., Bernasconi E., Ledergerber B., Gunthard H.F., Wong J.K. Role of retroviral restriction factors in the interferon-alpha-mediated suppression of HIV-1 in vivo. Proc. Nat. Acad. Sci. U.S.A. 2012, 109:3035-3040.
65. Radoshitzky S.R., Dong L., Chi X., Clester J.C., Retterer C., Spurgers K., Kuhn J.H., Sandwick S., Ruthel G., Kota K., Boltz D., Warren T., Kranzusch P.J., Whelan S.P., Bavari S. Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J. Virol. 2010, 84:10569-10580.
66. Ross S.R. Mouse mammary tumor virus molecular biology and oncogenesis. Viruses 2010, 2:2000-2012.
67. Schliemann C., Roesli C., Kamada H., Borgia B., Fugmann T., Klapper W., Neri D. In vivo biotinylation of the vasculature in B-cell lymphoma identifies BST-2 as a target for antibody-based therapy. Blood 2010, 115:736-744.
68. Shojaei F., Wu X., Qu X., Kowanetz M., Yu L., Tan M., Meng Y.G., Ferrara N. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models. Proc. Nat. Acad. Sci. U.S.A. 2009, 106:6742-6747.
69. Shojaei F., Wu X., Zhong C., Yu L., Liang X.H., Yao J., Blanchard D., Bais C., Peale F.V., van Bruggen N., Ho C., Ross J., Tan M., Carano R.A., Meng Y.G., Ferrara N. Bv8 regulates myeloid-cell-dependent tumour angiogenesis. Nature 2007, 450:825-831.
70. Sisirak V., Vey N., Goutagny N., Renaudineau S., Malfroy M., Thys S., Treilleux I., Labidi-Galy S.I., Bachelot T., Dezutter-Dambuyant C., Menetrier-Caux C., Blay J.Y., Caux C., Bendriss-Vermare N. Breast cancer-derived transforming growth factor-beta and tumor necrosis factor-alpha compromise interferon-alpha production by tumor-associated plasmacytoid dendritic cells. International journal of cancer. Int. J. Cancer 2013.
71. Skasko M., Wang Y., Tian Y., Tokarev A., Munguia J., Ruiz A., Stephens E.B., Opella S.J., Guatelli J. HIV-1 Vpu protein antagonizes innate restriction factor BST-2 via lipid-embedded helix-helix interactions. J. Biol. Chem. 2012, 287:58-67.
72. Staal, S.P., Hartley, J.W., Rowe, W.P., 1977. Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma. Proc. Nat. Acad. Sci. U S A 74, 3065-3067.
73. Staudt N.D., Jo M., Hu J., Bristow J.M., Pizzo D.P., Gaultier A., Vandenberg S.R., Gonias S.L. Myeloid cell receptor LRP1/CD91 regulates monocyte recruitment and angiogenesis in tumors. Cancer Res. 2013.
74. Stephens L.R., Eguinoa A., Erdjument-Bromage H., Lui M., Cooke F., Coadwell J., Smrcka A.S., Thelen M., Cadwallader K., Tempst P., Hawkins P.T. The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101. Cell 1997, 89:105-114.
75. Stewart T.H., Sage R.D., Stewart A.F., Cameron D.W. Breast cancer incidence highest in the range of one species of house mouse, Mus domesticus. Br. J. Cancer 2000, 82:446-451.
76. Suire S., Coadwell J., Ferguson G.J., Davidson K., Hawkins P., Stephens L. p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma. Current Boil. : CB 2005, 15:566-570.
77. Swiecki M., Wang Y., Gilfillan S., Lenschow D.J., Colonna M. Cutting edge: paradoxical roles of BST2/tetherin in promoting type I IFN response and viral infection. J. Immunol. (Baltimore, Md.: 1950) 2012, 188:2488-2492.
78. Szabo S., Haislip A.M., Garry R.F. Of mice, cats, and men: is human breast cancer a zoonosis?. Microsc. Res. Tech. 2005, 68:197-208.
79. Talapatra S., Thompson C.B. Growth factor signaling in cell survival: implications for cancer treatment. J. Pharmacol. Exp. Thera. 2001, 298:873-878.
80. Toulza F., Eliaou J.F., Pinet V. Breast tumor cell soluble factors induce monocytes to produce angiogenic but not angiostatic CXC chemokines. International journal of cancer. Int. J. Cancer 2005, 115:429-436.
81. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Ann. Rev. Biochem. 2001, 70:535-602.
82. Voigt P., Dorner M.B., Schaefer M. Characterization of p87PIKAP, a novel regulatory subunit of phosphoinositide 3-kinase gamma that is highly expressed in heart and interacts with PDE3B. J. Biol. Chem 2006, 281:9977-9986.
83. Wainwright D.A., Balyasnikova I.V., Han Y., Lesniak M.S. The expression of BST2 in human and experimental mouse brain tumors. Exp. Mol. Pathol. 2011, 91:440-446.
84. Walter-Yohrling J., Cao X., Callahan M., Weber W., Morgenbesser S., Madden S.L., Wang C., Teicher B.A. Identification of genes expressed in malignant cells that promote invasion. Cancer Res. 2003, 63:8939-8947.
85. Wang Y., Melana S.M., Baker B., Bleiweiss I., Fernandez-Cobo M., Mandeli J.F., Holland J.F., Pogo B.G. High prevalence of MMTV-like env gene sequences in gestational breast cancer. Med. Oncol. (Northwood, London, England) 2003, 20:233-236.
86. Watanabe R., Leser G.P., Lamb R.A. Influenza virus is not restricted by tetherin whereas influenza VLP production is restricted by tetherin. Virology 2011, 417:50-56.
87. Wu Y., Li Y.Y., Matsushima K., Baba T., Mukaida N. CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. J. Immunol. (Baltimore, Md.: 1950) 2008, 181:6384-6393.
88. Yan B., Wei J.J., Yuan Y., Sun R., Li D., Luo J., Liao S.J., Zhou Y.H., Shu Y., Wang Q., Zhang G.M., Feng Z.H. IL-6 cooperates with G-CSF To induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation. J. Immunol. (Baltimore, Md.: 1950) 2013, 190:5882-5893.
89. Yokoyama T., Enomoto T., Serada S., Morimoto A., Matsuzaki S., Ueda Y., Yoshino K., Fujita M., Kyo S., Iwahori K., Fujimoto M., Kimura T., Naka T. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer. International journal of cancer. Int. J. Cancer 2012.
90. Yoo H., Park S.H., Ye S.K., Kim M. IFN-gamma-induced BST2 mediates monocyte adhesion to human endothelial cells. Cell. Immunol. 2011, 267:23-29.
91. Young C.D., Nolte E.C., Lewis A., Serkova N.J., Anderson S.M. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3. Breast Cancer Res.: BCR 2008, 10:R70.
92. Zhang G.J., Adachi I. Serum interleukin-6 levels correlate to tumor progression and prognosis in metastatic breast carcinoma. Anticancer Res. 1999, 19:1427-1432.